Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition (OncoImmunology, 2016)

(untitled) - Eggink, F; Van Gool, I; Leary, A; Pollock, P; Crosbie, E; Mileshkin, L; Jordanova, E; Adam, J; Freeman-Mills, L; Church, D; Creutzberg, C; De Bruyn, M; et al.